RT Journal Article
SR Electronic
A1 Nierengarten, Mary Beth
T1 PROMETHEUS
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 10
SP 4
OP 5
DO 10.1177/1559897715590974
UL http://mdc.sagepub.com/content/15/10/4.abstract
AB The retrospective PROMETHEUS study demonstrated that patients with an acute coronary syndrome who underwent percutaneous coronary intervention were more likely to be treated by their physicians with prasugrel as opposed to clopidogrel if they were younger and had a lower risk factor burden. The adjusted rate of ischemic events and bleeding risk is similar with prasugrel and clopidogrel.